Your browser doesn't support javascript.
loading
The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.
Liu, Xuejiao; Chen, Xiangyu; Shi, Lin; Shan, Qianqian; Cao, Qiyu; Yue, Chenglong; Li, Huan; Li, Shengsheng; Wang, Jie; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong.
Afiliação
  • Liu X; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Chen X; Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Shi L; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Shan Q; Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Cao Q; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Yue C; Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Li H; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Li S; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Wang J; Surgical Department 9, Xuzhou children's hospital, Xuzhou, Jiangsu, China.
  • Gao S; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Niu M; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Yu R; Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
J Exp Clin Cancer Res ; 38(1): 219, 2019 May 23.
Article em En | MEDLINE | ID: mdl-31122294
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Sistema de Sinalização das MAP Quinases / Inibidores de Proteínas Quinases / Compostos de Anilina Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Sistema de Sinalização das MAP Quinases / Inibidores de Proteínas Quinases / Compostos de Anilina Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article